HRT Financial’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-35,618	Closed	-$5.4M	–	2974
2025 Q2	$5.4M	Buy	+35,618	New	+$4.75M	0.02%	496
2024 Q4	–	Sell	-14,769	Closed	-$2.91M	–	2544
2024 Q3	$2.91M	Buy	+14,769	New	+$3.07M	0.01%	714
2024 Q2	–	Sell	-4,856	Closed	-$1.31M	–	2351
2024 Q1	$1.31M	Buy	+4,856	New	+$1.16M	0.01%	756
2023 Q3	–	Sell	-22,835	Closed	-$4.8M	–	2496
2023 Q2	$4.8M	Buy	22,835 +6,002	+36%	+$1.19M	0.04%	298
2023 Q1	$3.4M	Buy	+16,833	New	+$3.81M	0.04%	378
2022 Q3	–	Sell	-9,891	Closed	-$2.12M	–	2907
2022 Q2	$2.12M	Buy	+9,891	New	+$2.42M	0.02%	546
2021 Q2	–	Sell	-58,879	Closed	-$17.1M	–	2951
2021 Q1	$17.1M	Buy	58,879 +1,990	+3%	+$553K	0.17%	67
2020 Q4	$14.2M	Buy	56,889 +18,401	+48%	+$4.38M	0.29%	58
2020 Q3	$8.71M	Buy	+38,488	New	+$7.99M	0.25%	68
2019 Q4	–	Sell	-7,104	Closed	-$940K	–	1220
2019 Q3	$940K	Buy	+7,104	New	+$952K	0.04%	384